|
| | 
|
 | |
        
|  |
|  |
|
 BAYER SCHERING PH - [Ticker: SCH.F] |     | | Última Transacción | | Hora de Cotización | N/A - N/A | | Variación | () | Rango 52 Semanas | [0,000 - 0,000] | | Máximo | | Mínimo | | | Volumen | | Volumen Medio (3m) | 0 | | Demanda / Oferta | N/A | Yield | N/A | | Cierre Anterior | 0,000 | PER | N/A | | Apertura | | EPS | 0,00 | | Fecha Ex-Dividendo | N/A | Fecha Dividendo | N/A | | Capitalización Bursátil | 0 | Objetivo Estimado 1 Año | N/A | | Nota: Los datos pueden tener un retraso de algunos minutos. |
| | Ver cotizaciones de otros activos |
| Últimos 10 Tópicos en el Foro relacionados con BAYER SCHERING PH: | | No se han encontrado tópicos relacionados con BAYER SCHERING PH [SCH.F], pero se aconseja la búsqueda en el Foro para tópicos relacionados con BAYER SCHERING PH. |
|
Noticias de BAYER SCHERING PH [SCH.F]: (ordenadas por relevancia)
|
|
Gould Class of 2012 graduates SaturdayBethel CitizenFollowing its acquisition by Schering-Plough, Dr. Lee was appointed director of molecular biology research and helped DNAX become a leader in research on the immune system in the 1980s and 1990s. Dr. Lee then joined Millennium Pharmaceuticals in ... |
|
Makucell? Appoints International Life Sciences Business Leader and ...EON: Enhanced Online News (press release)Dr. Scanlon was the CEO/Co-Founder of Melanoma Diagnostics, acquired by Myriad in 2010, and a Vice President at Berlex/Schering AG, where he was responsible for the development of medical products for diagnostics and small molecule projects in Europe, ... |
|
Rudolph Neri, 83NorthJersey.comBorn in South Barre, Mass., he came to Hawthorne in 1956 after graduating from Holy Cross College with a BA Degree and received his master's degree and Ph.D at New York University. He was employed at Schering Plough (now Merck) Pharmaceutical Co. as ... |
|
Cynapsus Therapeutics Nominates New Directors for BoardHealthcare Global (press release)Most of his career was spent at Abbott (17 years) although he has worked at Pharmacia, Oxford Bioscience Partners, Schering Plough and Merck. He has a strong track record of making significant contributions to company growth by closing transactions ...y más » |
|
Jones Lang LaSalle Incorporated's CEO Discusses Q1 2012 Results ...Seeking AlphaMajor leasing and tenant representation assignments completed during the quarter included a 355000 square foot lease in Dublin from Merck/Schering-Plough. LaSalle Investment Management continued to deliver strong performance for its clients during the ... |
| Para más noticias de BAYER SCHERING PH hacer clic aquí:
Noticias de BAYER SCHERING PH |
|
Anchura de la Página:
Imagen de Fondo: |
|  | |
|
|
![Gráfico de BAYER SCHERING PH - [Ticker: SCH.F]](http://www.bolsaes.com/grafico/bolsaes-SCH.F-1-ano.png "Gráfico 1 Año de BAYER SCHERING PH [SCH.F] BolsaES")
